Abstract | BACKGROUND: OBJECTIVE: Our aim was to arrive at a consensus on treating psoriasis in patients with concomitant HCV infection. METHODS: Reports in the literature were reviewed regarding common psoriasis therapies and liver toxicity. RESULTS: LIMITATIONS: CONCLUSIONS: There are no large double-blind clinical trials addressing the treatment of psoriasis in patients with HCV infection and more studies are needed.
|
Authors | Amylynne J Frankel, Abby S Van Voorhees, Sylvia Hsu, Neil J Korman, Mark G Lebwohl, Bruce F Bebo Jr, Alice B Gottlieb, National Psoriasis Foundation |
Journal | Journal of the American Academy of Dermatology
(J Am Acad Dermatol)
Vol. 61
Issue 6
Pg. 1044-55
(Dec 2009)
ISSN: 1097-6787 [Electronic] United States |
PMID | 19811848
(Publication Type: Journal Article, Meta-Analysis, Review)
|
Topics |
- Hepatitis C, Chronic
(complications, drug therapy)
- Humans
- Liver
(drug effects)
- Psoriasis
(complications, drug therapy)
|